期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review
1
作者 fangfang geng Meifang YANG +3 位作者 Xuan ZHANG Hong ZHAO De ZHOU Jianhua HU 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2023年第12期1159-1164,共6页
Cytomegalovirus(CMV)infection is currently prevalent in populations throughout the world,and 56%-94%of the global population is seropositive for CMV.CMV infection mainly affects immunocompromised hosts.In these cases,... Cytomegalovirus(CMV)infection is currently prevalent in populations throughout the world,and 56%-94%of the global population is seropositive for CMV.CMV infection mainly affects immunocompromised hosts.In these cases,it can cause significant symptoms,tissue-invasive disease,and many sequelae including death(Dioverti and Razonable,2016).The vast majority of healthy adults with CMV infection experience an asymptomatic course;when symptomatic,it manifests as a mononucleosis-like syndrome in approximately 10%of patients(Sridhar et al.,2018). 展开更多
关键词 INFECTION IMMUNO
原文传递
Development and Validation of a Novel Noninvasive Model to Predict Liver Fibrosis Staging in Untreated Patients with Chronic Hepatitis B
2
作者 Jianhua Hu Xiaoli Zhang +8 位作者 Zhibo Zhou fangfang geng Hongyu Jia Linfeng Jin Weixiang Zhong Guodong Yu Xue Wen Hainv Gao Yida Yang 《Journal of Clinical and Translational Hepatology》 2025年第10期899-903,共5页
Hepatitis B virus infection represents a major global public health challenge.1 Chronic hepatitis B(CHB)virus infection is a leading cause of liver fibrosis,a key pathological process that drives the progression of ch... Hepatitis B virus infection represents a major global public health challenge.1 Chronic hepatitis B(CHB)virus infection is a leading cause of liver fibrosis,a key pathological process that drives the progression of chronic liver disease to cirrhosis.Current clinical guidelines recommend the immediate initiation of antiviral therapy upon detection of significant liver fibrosis in patients with CHB.2–4 Early-stage fibrosis may be reversible with effective antiviral treatment,whereas advanced fibrosis or cirrhosis shows limited reversibility despite therapy.5 As such,early identification and staging of liver fibrosis,followed by timely antiviral intervention,are crucial for optimizing the management of CHB and improving longterm patient outcomes. 展开更多
关键词 liver fibrosisa liver fibrosis DEVELOPMENT clinical guidelines VALIDATION noninvasive model chronic liver disease hepatitis b virus
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部